856 related articles for article (PubMed ID: 18936687)
1. Diagnostic utility of antibody to smoothelin in the distinction of muscularis propria from muscularis mucosae of the urinary bladder: a potential ancillary tool in the pathologic staging of invasive urothelial carcinoma.
Paner GP; Shen SS; Lapetino S; Venkataraman G; Barkan GA; Quek ML; Ro JY; Amin MB
Am J Surg Pathol; 2009 Jan; 33(1):91-8. PubMed ID: 18936687
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens.
Paner GP; Brown JG; Lapetino S; Nese N; Gupta R; Shen SS; Hansel DE; Amin MB
Am J Surg Pathol; 2010 Jun; 34(6):792-9. PubMed ID: 20421781
[TBL] [Abstract][Full Text] [Related]
3. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma.
Paner GP; Ro JY; Wojcik EM; Venkataraman G; Datta MW; Amin MB
Am J Surg Pathol; 2007 Sep; 31(9):1420-9. PubMed ID: 17721199
[TBL] [Abstract][Full Text] [Related]
4. Pitfalls in the use of smoothelin to identify muscularis propria invasion by urothelial carcinoma.
Miyamoto H; Sharma RB; Illei PB; Epstein JI
Am J Surg Pathol; 2010 Mar; 34(3):418-22. PubMed ID: 20154589
[TBL] [Abstract][Full Text] [Related]
5. Muscularis mucosae versus muscularis propria in gallbladder, cystic duct, and common bile duct: smoothelin and desmin immunohistochemical study.
Raparia K; Zhai QJ; Schwartz MR; Shen SS; Ayala AG; Ro JY
Ann Diagn Pathol; 2010 Dec; 14(6):408-12. PubMed ID: 21074688
[TBL] [Abstract][Full Text] [Related]
6. Limited smoothelin expression within the muscularis mucosae: validation in bladder diverticula.
Hansel DE; Paner GP; Nese N; Amin MB
Hum Pathol; 2011 Nov; 42(11):1770-6. PubMed ID: 21683983
[TBL] [Abstract][Full Text] [Related]
7. Smoothelin immunohistochemistry is a useful adjunct for assessing muscularis propria invasion in bladder carcinoma.
Bovio IM; Al-Quran SZ; Rosser CJ; Algood CB; Drew PA; Allan RW
Histopathology; 2010 Jun; 56(7):951-6. PubMed ID: 20636795
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of immunohistochemical markers in bladder smooth muscle and myofibroblasts, and the potential utility of desmin, smoothelin, and vimentin in staging of bladder carcinoma.
Council L; Hameed O
Mod Pathol; 2009 May; 22(5):639-50. PubMed ID: 19252475
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical staining for smoothelin in the duplicated versus the true muscularis mucosae of Barrett esophagus.
Faragalla HF; Marcon NE; Yousef GM; Streutker CJ
Am J Surg Pathol; 2011 Jan; 35(1):55-9. PubMed ID: 21164287
[TBL] [Abstract][Full Text] [Related]
10. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
Tamas EF; Epstein JI
Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
[TBL] [Abstract][Full Text] [Related]
11. Antigenic profile of muscularis mucosae and muscularis propria of the urinary bladder.
Poletajew S; Wilczek E; Wasiutyński A; Górnicka B
Iran J Immunol; 2015 Mar; 12(1):50-63. PubMed ID: 25784097
[TBL] [Abstract][Full Text] [Related]
12. Smoothelin is a specific and robust marker for distinction of muscularis propria and muscularis mucosae in the gastrointestinal tract.
Montani M; Thiesler T; Kristiansen G
Histopathology; 2010 Aug; 57(2):244-9. PubMed ID: 20716166
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical differentiation between muscularis mucosae and muscularis propria for improving the staging of bladder cancer in patients undergoing transurethral resection of bladder tumours.
Poletajew S; Wolińska E; Wasiutyński A; Dybowski B; Radziszewski P; Górnicka B
Pol J Pathol; 2017; 68(3):218-224. PubMed ID: 29363913
[TBL] [Abstract][Full Text] [Related]
14. Significance of muscularis mucosae in metastasis involvement of urinary bladder transitional cell carcinoma.
Chaimuangraj S; Dissaranan C; Leenanupunth C; Prathombutr P; Chalermsanyakorn P
J Med Assoc Thai; 2006 Sep; 89(9):1447-53. PubMed ID: 17100383
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Tumor Depth Invasion With Anti-Smoothelin Antibody in Equivocal Transurethral Resection of Urinary Bladder Tumor Surgical Specimens.
Mihai IM; Olteanu GE; Herman D; Anderco D; Iacob M; Nataras B; Cumpanas AA; Bardan R; Dema A
Int J Surg Pathol; 2021 Feb; 29(1):54-63. PubMed ID: 33090031
[TBL] [Abstract][Full Text] [Related]
16. Large nested variant of urothelial carcinoma: 23 cases mimicking von Brunn nests and inverted growth pattern of noninvasive papillary urothelial carcinoma.
Cox R; Epstein JI
Am J Surg Pathol; 2011 Sep; 35(9):1337-42. PubMed ID: 21836490
[TBL] [Abstract][Full Text] [Related]
17. Detection of smoothelin expression in the urinary bladder is strongly dependent on pretreatment conditions: a critical analysis with possible consequences for cancer staging.
Lindh C; Nilsson R; Lindstrom ML; Lundin L; Elmberger G
Virchows Arch; 2011 Jun; 458(6):665-70. PubMed ID: 21494761
[TBL] [Abstract][Full Text] [Related]
18. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder.
Westfall DE; Folpe AL; Paner GP; Oliva E; Goldstein L; Alsabeh R; Gown AM; Amin MB
Am J Surg Pathol; 2009 Jan; 33(1):99-105. PubMed ID: 18941404
[TBL] [Abstract][Full Text] [Related]
19. Impact of second opinion pathology in the definitive management of patients with bladder carcinoma.
Coblentz TR; Mills SE; Theodorescu D
Cancer; 2001 Apr; 91(7):1284-90. PubMed ID: 11283928
[TBL] [Abstract][Full Text] [Related]
20. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
